Evidence map›Paper›PMID 39741205›Full record

ArticleCommunications medicine2024

The impact of gender-affirming interventions on eating disorder diagnosis risk among transgender and gender-diverse individuals.

Matthew Loria, Tomasz Tabernacki, Elad Fraiman, Jaime Perez, Jessica Abou Zeki, Julia Palozzi, Carly Goldblatt, Shubham Gupta, Kirtishri Mishra, Megan McNamara and 1 more

Abstract read
In one paragraph

Article in Communications medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Exploring the Intersection of Gender Identity and Eating Behaviours in Gender-Diverse Populations.European eating disorders review : the journal of the Eating Disorders Association · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Matthew Loria *Case Western Reserve University School of Medicine, Cleveland, USA. mml140@case.edu.ORCID http://orcid.org/0009-0000-5982-3931
Tomasz Tabernacki *Case Western Reserve University School of Medicine, Cleveland, USA.ORCID http://orcid.org/0000-0003-0650-3349
Elad FraimanCase Western Reserve University School of Medicine, Cleveland, USA.
Jaime PerezUniversity Hospital's Urology Institute, Lyndhurst, USA.
Jessica Abou ZekiCase Western Reserve University School of Medicine, Cleveland, USA.
Julia PalozziUniversity of Colorado, Department of Psychiatry, Boulder, USA.
Carly GoldblattCase Western Reserve University School of Medicine, Cleveland, USA.
Shubham GuptaUniversity Hospital's Urology Institute, Lyndhurst, USA.
Kirtishri MishraCase Western Reserve University School of Medicine, Cleveland, USA.
Megan McNamaraVeterans Affairs, Louis Stokes, Cleveland, USA.
Swagata BanikBaldwin Wallace University, Berea, USA.

Funding

Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages to Equity in Health (CLE Health)UM1TR004528 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI GRACE A MCCOMSEY · 2023 to 2026
$32.1M
NCATS NIH HHS UM1 TR004528
6 · The paper itself

Abstract

backgroundThe objective of this study is to evaluate the risk of being diagnosed with an eating disorder among transgender and gender-diverse (TGD) individuals, specifically examining how this risk differs following gender-affirming medical therapy (GAMT).

methodsThe study utilizes electronic medical record (EMR) data from the TriNetX database. A total of 90,955 TGD individuals were identified in the TriNetX database. TGD individuals were divided into cohorts according to gender-affirming interventions they received. To assess the risk of eating disorder diagnoses across groups, we applied a Cox proportional hazards model with gender-affirming care as a time-varying covariate.

resultsHere we show that transfeminine individuals receiving hormone therapy (HT) have a significantly higher likelihood of being diagnosed with an eating disorder compared to those without intervention (HR:1.67, 95% CI:1.41, 1.98). Conversely, transmasculine individuals on HT exhibit a reduced risk of being diagnosed with an eating disorder relative to those without intervention (HR: 0.83, 95% CI: 0.76, 0.90).

conclusionsAfter undergoing gender-affirming medical therapy, the risk of eating disorder diagnosis increases for transfeminine individuals and decreases for transmasculine individuals. The observed differences in risk between transfeminine and transmasculine individuals on GAMT may be attributed to factors such as gendered societal norms, variations in screening practices, and the physiological effects of hormone therapy on eating disorder symptomatology. Further research is needed to clarify these influences and support tailored interventions.

Identifiers

PMID39741205
PMCPMC11688434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.